Results
Lake Street Capital Markets LLC
02/03/2026 | Press release | Archived content
Plus Therapeutics, Inc. (PSTV) - Initiation of Coverage
Lake Street Capital Markets Analyst, Chad Messer, initiated coverage of Plus Therapeutics, Inc. with a BUY rating and price target of $2 (PSTV-$2). Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.
Want to stay up-to-date with the latest at Lake Street? Subscribe to our mailing list!
NameEmail Address
Thanks for joining our mailing list.
Oops! Something went wrong while submitting the form.
Lake Street Capital Markets LLC published this content on February 03, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 16, 2026 at 10:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]